
Photo Credit: Günter Valda
Scientific Frontline: Extended "At a Glance" Summary: Hemostatic B-Knob Triggered Microgels (BK-TriGs)
The Core Concept: B-knob triggered microgels (BK-TriGs) are injectable, engineered hydrogel particles designed to safely reduce bleeding in infants undergoing surgery. By mimicking the mechanical properties of natural platelets and utilizing specialized amino acid sequences, these microgels facilitate efficient blood clotting tailored specifically to neonatal biology.
Key Distinction/Mechanism: Traditional neonatal surgical care relies on adult blood transfusions, which introduce severe risks of excessive clotting and thrombosis due to fundamental differences between adult and infant hemostasis. BK-TriGs circumvent this complication by utilizing functionalized B peptides to directly target and bridge fibrinogen "hole b" sites within the infant's own plasma. This mechanism increases clot density and stabilizes the fibrin network without the risks associated with adult blood products.
Major Frameworks/Components:
- Microgel Particles (Hydrogels): Water-absorbing polymers engineered to emulate the mechanical properties of natural blood platelets.
- Fibrin and B Peptides: Fibrin is the primary clotting protein in human blood; B peptides are short amino acid sequences that link fibrin molecules together to form clots and play a critical role in neonatal hemostasis.
- Fibrinogen Hole B Sites: Specific biological binding sites targeted by the BK-TriGs to enhance the density, stability, and degradation resistance of the resulting blood clot.



.jpg)


.jpg)





.jpg)



%20(resized).jpg)
